SWISSE Wellness has announced that the first female participant is enrolled in the 'Swisse High Strength Cranberry supplementation for prevention of recurrent urinary tract infection trial', which is the first trial under the company's CSIRO strategic Research Agreement signed last year (PD 27 Oct 16).
The trial will run for a two-year period, with 300 participants recruited across sites in both Australia and China.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 May 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 May 17